Ultragenyx Pharmaceutical Inc (MEX:RARE)
MXN 751.98 0 (0%) Market Cap: 65.87 Bil Enterprise Value: 59.05 Bil PE Ratio: 0 PB Ratio: 23.46 GF Score: 70/100

Ultragenyx Pharmaceutical Inc Annual Shareholders Meeting Transcript

Jun 26, 2020 / 03:00PM GMT
Release Date Price: MXN1323.83
Operator

Ladies and gentlemen, welcome to the Ultragenyx Pharmaceutical 2020 Annual Shareholder Meeting.

I will now turn things over to Chairman, Dan Welch.

Daniel G. Welch
Ultragenyx Pharmaceutical Inc. - Independent Non-Executive Chairman

Good morning, ladies and gentlemen, and welcome to the 2020 Annual Meeting of Stockholders of Ultragenyx Pharmaceutical Inc. My name is Dan Welch, and I serve as the Chairman of the Board. I'll be presiding over this meeting.

At this time, I call the meeting to order. Emil Kakkis, the President and CEO, is present and will walk us through the rest of the meeting. Emil?

Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - President, CEO & Director

Thank you, Dan. Joining us today are Bill Aliski, Chair of the Compensation Committee; Lars Ekman, Chair of the Research and Development Committee; Matt Fust, Chair of the Audit and Nominating and Corporate Governance Committee; Michael Narachi, Director; Shehnaaz Suliman, Director; Karah Parschauer, Executive Vice President

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot